Kobayashi Pharmaceutical Co Ltd
TSE:4967

Watchlist Manager
Kobayashi Pharmaceutical Co Ltd Logo
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Watchlist
Price: 5 989 JPY -0.08% Market Closed
Market Cap: 445.2B JPY
Have any thoughts about
Kobayashi Pharmaceutical Co Ltd?
Write Note
Kobayashi Pharmaceutical Co Ltd
/
Balance Sheet
/
Current Portion of Long-Term Debt

Kobayashi Pharmaceutical Co Ltd
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Kobayashi Pharmaceutical Co Ltd
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Current Portion of Long-Term Debt
¥371m
CAGR 3-Years
30%
CAGR 5-Years
20%
CAGR 10-Years
13%
Shiseido Co Ltd
TSE:4911
Current Portion of Long-Term Debt
¥144B
CAGR 3-Years
77%
CAGR 5-Years
33%
CAGR 10-Years
4%
Rohto Pharmaceutical Co Ltd
TSE:4527
Current Portion of Long-Term Debt
¥24.3B
CAGR 3-Years
64%
CAGR 5-Years
70%
CAGR 10-Years
10%
Kao Corp
TSE:4452
Current Portion of Long-Term Debt
¥56.4B
CAGR 3-Years
37%
CAGR 5-Years
4%
CAGR 10-Years
11%
Kose Corp
TSE:4922
Current Portion of Long-Term Debt
¥1.5B
CAGR 3-Years
98%
CAGR 5-Years
46%
CAGR 10-Years
25%
F
Fancl Corp
TSE:4921
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Kobayashi Pharmaceutical Co Ltd
Glance View

Market Cap
445.2B JPY
Industry
Consumer products

In the bustling landscape of Japanese business, Kobayashi Pharmaceutical Co., Ltd. stands as an epitome of innovation and tradition. Founded in 1886, this company, steeped in history, has consistently demonstrated a knack for transforming simple consumer needs into thriving business opportunities. Core to its operations is the development, manufacturing, and marketing of consumer healthcare products that subtly blend pharmaceutical expertise with daily convenience. This approach has allowed Kobayashi Pharmaceutical to carve out a distinctive niche, particularly in over-the-counter (OTC) health and personal care products. The company's vast array of products is remarkably diverse, ranging from cooling gel sheets for fevers to herbal medicinal drinks, each crafted with an understanding of consumer pain points and a commitment to well-being. What sets Kobayashi apart in the competitive market is its strategic focus on niche products that serve unmet needs. This laser-sharp business model does more than just bolster its domestic market; it drives its global expansion into key markets in Asia, North America, and Europe. The company's profitability hinges not just on innovation but also on its agile response to the shifting preferences of health-conscious consumers. Driven by a mission to deliver "small but valuable products," Kobayashi’s nimble approach, coupled with an impressive R&D focus, ensures that it remains at the forefront of both consumer satisfaction and shareholder value. Much like a well-crafted Japanese garden, every part of Kobayashi's operation is meticulously designed to function harmoniously, making it a standout player in the global consumer healthcare industry.

Intrinsic Value
6 793.41 JPY
Undervaluation 12%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Kobayashi Pharmaceutical Co Ltd's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
371m JPY

Based on the financial report for Sep 30, 2024, Kobayashi Pharmaceutical Co Ltd's Current Portion of Long-Term Debt amounts to 371m JPY.

What is Kobayashi Pharmaceutical Co Ltd's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 10Y
13%

Over the last year, the Current Portion of Long-Term Debt growth was 8%. The average annual Current Portion of Long-Term Debt growth rates for Kobayashi Pharmaceutical Co Ltd have been 30% over the past three years , 20% over the past five years , and 13% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.